KELLY MURRAY: Open Payments
NPI 1821388836 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,699 in 100 payments from 18 companies in 2025. Trend: 2023 $1,571 · 2024 $6,574 · 2025 $6,699
Speaker / faculty: $2,344Travel & lodging: $2,146Food & beverage: $2,047Education: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $5,495 |
| Janssen Biotech, Inc. | 14 | $274 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Galderma Laboratories, L.P. | 4 | $86 |
| Lilly USA, LLC | 4 | $83 |
| LEO Pharma Inc. | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| GENZYME CORPORATION | 2 | $76 |
| PFIZER INC. | 3 | $71 |
| Organon LLC | 3 | $58 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, TALTZ, COSENTYX, CIBINQO.
Industry payments across GA — which companies pay providers there.
